OECD · Health

Latvia: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted

69.20US dollars per person, PPP converted · 2025+106.6% since 2015

OECD dataflow OECD.ELS.HD:HEALTH_PHMC@DF_PHMC_SALES. Pharmaceutical sales: Antiinfectives for systemic use (US dollars per person, PPP converted). Annual figures for Latvia from 2001 to 2025.

20012025

Every year

YearValue (US dollars per person, PPP converted)Note
202569.2
202472.3
202373.6
202263.1
202158.5
202069.8
201960.4
201869
201759.9
201654.5
201533.5
201429.4
201329.8
201226.9
201124.8
201023.6
200920.3
200820.7
200716.9
200616.9
200522.5
200419.2
200314.5
200216.1
200110.1

Source

Published by OECD, produced by OECD. Licence: OECD terms (CC BY 4.0). Retrieved 2026-11-17.

The dataset for every country, with quality and provenance →

Cite or download

OECD (2026). Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted. Interva. https://interva.co/dataset/oecd-df-phmc-sales-ph-sales-z-j-usd-ppp-ps (accessed 2026-11-21). catalog snapshot 2026-11-17.

JSON, LatviaAPI and MCP

Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted in other countries

Rank Latvia against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Latvia: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted (2001–2025) · Interva